Unique COVID-19 PCR Testing Focus Provista Diagnostics is investing 100% of its COVID-19 PCR testing profits into creating life-saving diagnostic solutions. Leveraging this focus on COVID-19 testing can open doors for partnerships or collaborations with healthcare facilities, clinics, and organizations aiming to enhance their diagnostic capabilities.

Strategic Acquisition by Todos Medical Ltd. The acquisition of Provista Diagnostics by Todos Medical Ltd. has positioned them to access Provista's proprietary commercial-stage Videssa® breast cancer blood test. Utilizing this strategic partnership, sales professionals can explore cross-selling opportunities to introduce complementary diagnostic solutions to existing and potential clients.

Cutting-Edge Tech Stack for Enhanced Solutions Provista Diagnostics employs a sophisticated tech stack including React, Google Analytics, and HubSpot, reflecting their commitment to innovation. Demonstrating how these technologies can streamline diagnostic processes or improve patient outcomes can attract tech-savvy clients seeking advanced healthcare solutions.

Focus on Women's Health & Videssa Breast Cancer Detection With Provista Diagnostics emphasizing diagnostics for Women's Health and the upcoming launch of Videssa Breast Cancer Detection, sales professionals can target healthcare providers specializing in women's health services, cancer treatment centers, and research institutions interested in cutting-edge breast cancer detection technologies.

Strategically Located in Georgia, USA Being headquartered in Alpharetta, Georgia, Provista Diagnostics can leverage its location to establish strong local partnerships with medical facilities, testing centers, and healthcare providers in the region. Sales reps can capitalize on proximity and familiarity with the local market to drive sales growth and expansion.